Yigal Nochomovitz
Stock Analyst at Citigroup
(3.42)
# 1,021
Out of 4,667 analysts
280
Total ratings
44.44%
Success rate
4.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $37 → $45 | $15.95 | +182.13% | 7 | Nov 19, 2024 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $40 → $49 | $24.31 | +101.56% | 10 | Nov 12, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $63 → $51 | $27.49 | +85.52% | 14 | Nov 6, 2024 | |
| KRYS Krystal Biotech | Maintains: Neutral | $204 → $206 | $178.10 | +15.67% | 3 | Nov 5, 2024 | |
| ARDX Ardelyx | Maintains: Buy | $12 → $10 | $4.92 | +103.25% | 14 | Nov 4, 2024 | |
| ZYME Zymeworks | Maintains: Buy | $16 → $18 | $14.55 | +23.71% | 15 | Nov 4, 2024 | |
| ZBIO Zenas BioPharma | Initiates: Buy | $27 | $12.45 | +116.87% | 1 | Oct 8, 2024 | |
| STTK Shattuck Labs | Downgrades: Neutral | $8 → $2 | $1.11 | +80.18% | 4 | Oct 2, 2024 | |
| SMMT Summit Therapeutics | Downgrades: Neutral | $19 → $23 | $18.62 | +23.52% | 4 | Sep 27, 2024 | |
| APLT Applied Therapeutics | Maintains: Buy | $8 → $11 | $9.43 | +16.65% | 8 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $27.41 | +31.34% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $25.54 | +127.09% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $6.28 | +250.32% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $3.28 | +326.83% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $288 | $194.26 | +48.25% | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $93 | $42.93 | +116.63% | 15 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.04 | +15.38% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $14.62 | +159.92% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $84 | $47.26 | +77.74% | 20 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $8.74 | +60.18% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $3.67 | -45.50% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $33.91 | +0.27% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $26.23 | +151.62% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $36 → $55 | $22.69 | +142.40% | 8 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $16.17 | +196.85% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $8.28 | +141.55% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $4.76 | +68.07% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $10.68 | +227.72% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $46.40 | +186.64% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.81 | +890.83% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $1.17 | +412.82% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.91 | +737.70% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $2.22 | +350.45% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.65 | +869.70% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.28 | +1,241.46% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.69 | +611.95% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $38 | $1.96 | +1,838.78% | 4 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.84 | - | 14 | Sep 28, 2021 |
Syndax Pharmaceuticals
Nov 19, 2024
Maintains: Buy
Price Target: $37 → $45
Current: $15.95
Upside: +182.13%
Rigel Pharmaceuticals
Nov 12, 2024
Maintains: Buy
Price Target: $40 → $49
Current: $24.31
Upside: +101.56%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $27.49
Upside: +85.52%
Krystal Biotech
Nov 5, 2024
Maintains: Neutral
Price Target: $204 → $206
Current: $178.10
Upside: +15.67%
Ardelyx
Nov 4, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $4.92
Upside: +103.25%
Zymeworks
Nov 4, 2024
Maintains: Buy
Price Target: $16 → $18
Current: $14.55
Upside: +23.71%
Zenas BioPharma
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $12.45
Upside: +116.87%
Shattuck Labs
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.11
Upside: +80.18%
Summit Therapeutics
Sep 27, 2024
Downgrades: Neutral
Price Target: $19 → $23
Current: $18.62
Upside: +23.52%
Applied Therapeutics
Sep 19, 2024
Maintains: Buy
Price Target: $8 → $11
Current: $9.43
Upside: +16.65%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $27.41
Upside: +31.34%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $25.54
Upside: +127.09%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $6.28
Upside: +250.32%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $3.28
Upside: +326.83%
Aug 8, 2024
Maintains: Buy
Price Target: $269 → $288
Current: $194.26
Upside: +48.25%
Jun 26, 2024
Maintains: Buy
Price Target: $70 → $93
Current: $42.93
Upside: +116.63%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.04
Upside: +15.38%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $14.62
Upside: +159.92%
May 23, 2024
Maintains: Buy
Price Target: $89 → $84
Current: $47.26
Upside: +77.74%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $8.74
Upside: +60.18%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $3.67
Upside: -45.50%
Apr 10, 2024
Initiates: Buy
Price Target: $34
Current: $33.91
Upside: +0.27%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $26.23
Upside: +151.62%
Feb 15, 2024
Downgrades: Neutral
Price Target: $36 → $55
Current: $22.69
Upside: +142.40%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $16.17
Upside: +196.85%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $8.28
Upside: +141.55%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $4.76
Upside: +68.07%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $10.68
Upside: +227.72%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $46.40
Upside: +186.64%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.81
Upside: +890.83%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $1.17
Upside: +412.82%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.91
Upside: +737.70%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $2.22
Upside: +350.45%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $1.65
Upside: +869.70%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.28
Upside: +1,241.46%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.69
Upside: +611.95%
Aug 29, 2022
Maintains: Buy
Price Target: $39 → $38
Current: $1.96
Upside: +1,838.78%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.84
Upside: -